Clinical Evaluation of Latent Visceral Leishmaniasis in US Service
Methods. A recent surveillance study tested 112 asymptomatic US service members previously deployed to Iraq for latent VL with interferon gamma release assays (IGRA), enzyme-linked immunosorbent assays (ELISA), rK39 immunochromatographic tests, and quantitative polymerase chain reactions (PCR). Persons with any positive result were offered a clinical consultation to assess for exposure risks, immune-suppressing conditions, and evidence of active VL, as well as to obtain baseline laboratory studies and abdominal imaging, as needed, and to provide counseling. This is a case series of the 18 subjects who underwent clinical evaluation.
Results. Among 18 latent VL subjects evaluated, 14 were IGRA+, 4 ELISA+, 0 rK39+, and 1 PCR+ (3 parasites/ml). All were male and median age was 38.5 years. Initial deployments were in 2003-2008 and median total duration in Iraq was 17 months. Musculoskeletal disease was the most common comorbidity. Four subjects previously had cutaneous leishmaniasis. One subject had psoriatic arthritis and prior TNF-α inhibitor exposure, but no other substantial risks for immunosuppression were identified. There was no evidence of active VL, although one subject had thrombocytopenia and two had elevated liver enzymes. There was no abnormal imaging. No subjects were treated and those that were PCR+ and ELISA+ are being followed clinically.
Conclusion. This series highlights the first 18 US service members diagnosed with latent VL. No patients have active disease, most have an appropriate immune response (IGRA), four have a T H 2 humoral immune response (one of whom is immunosuppressed), and one has evidence of ineffective immune control with circulating parasites. We have developed an approach to the assessment and counseling of latent VL. Further studies are needed to assess the natural history and treatment of latent VL. Background. Leishmaniasis is a zoonotic parasitic disease transmitted by sand fly bites. Visceral leishmaniasis (VL) is a chronic intracellular infection which, when symptomatic, can be fatal without therapy. Subclinical or latent VL may occur in a majority of those infected with lifelong risk of activation when immunosuppressed. Symptomatic VL has been described in Soldiers deployed to Operation Iraqi Freedom (OIF). We report the prevalence and risk characteristics of latent VL infection in OIF Soldiers.
Methods. Healthy soldiers deployed during summer months (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) to VL endemic areas of Iraq were recruited from Fort Bliss, Texas. Responses to a risk factor survey and blood samples were obtained. Leishmania research diagnostics were performed on serum and/or white blood cells to include ELISA, rk39 immunochromatography, qPCR, and interferon gamma release (IGRA) assays. Analyses included descriptive percentages and other summary statistics. Fisher's exact test and logistic regression were used for group comparisons.
Results. Out of 88 subjects enrolled, 76/88 (86%) were male with median age 39 years and deployment duration of 365 days. The prevalence of latent VL was 10.2% (CI 4.8%-18.5%) with seven IGRA positive and two ELISA positive. Travel to Ninewa governate correlated with VL, P < 0.05. No significant differences were noted in occupation, personal protective measures, deployment timeframe, or sleeping conditions between VL positive and negative individuals. In persons with latent VL, 4/9 (44.4%) and 6/9 (66.7%) deployed to Ninewa and Baghdad respectively, 7/9 (77.8%) were outdoors most nights, 5/9 (55.6%) slept on the ground during deployment, 5/9 (55.6%) were medical personnel, 7/9 (77.8%) slept in less than full uniform, and 8/9 (88.9%) never or rarely used insect repellent.
Conclusion. Latent VL was identified in asymptomatic OIF Soldiers (10.2%). Travel to Ninewa governate correlated with VL infection. In the latent VL group, many were healthcare workers, slept on the ground or in less than full uniform, and rarely used insect repellent. Further studies are needed to inform risk of reactivation disease in latently infected US Soldiers and to target measures for broader surveillance and safety, such as the screening of military blood donors.
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Imported Malaria in Travelers Presenting to a Tertiary
Methods. We conducted a retrospective review of 90 cases of malaria seen at a single urban university hospital during 2000-2016.
Results. Of the 90 cases, 77% were Plasmodium falciparum, 14% were either P. ovale or P. vivax, 1% was P. malariae, and the rest were mixed or unknown. Eighty-one patients had traveled to Africa, four to Asia, four to more than one continent, and one to Haiti. Mean age was 41, and 59% were male. The main presenting symptoms were fever (92%), chills (78%), and headache (66%); 10% presented with cerebral malaria. Thirteen cases were managed as outpatients, 59 on a medical ward, and 18 in the ICU. Fourteen (16%) had severe malaria; these were more likely to present with hypotension, non-segmented neutrophilia, hyponatremia, metabolic acidosis, and acute kidney injury (all P < 0.01). Thrombocytopenia was more severe in patients with severe malaria (54,000 vs. 113,000, P < 0.01). Treatment included quinine-based therapy (38%), atovaquone/ proguanil (31%), artemether/lumefantrine (19%), and chloroquine/primaquine (11%). Twenty (22%) required change of treatment regimen due to inadequate clinical response or adverse effects. The most common in-hospital complications were ARDS (8%), QT prolongation (7%), and nosocomial infection (4%). Two patients were pregnant at the time of presentation; one suffered severe malaria and fetal loss. Only 3% of patients reported being prescribed a prophylactic regimen and completing it; 20% reported taking an incomplete course, and the majority took no prophylaxis at all. Of 27 patients who had presented to another United States-based medical provider prior to hospitalization, 11 were initially misdiagnosed and treated for conditions other than malaria, including two who underwent extensive hematologic investigations. Inadequate experience and resources in treating malaria were the primary reasons cited for transfer to the tertiary hospital from community-based providers.
Conclusion. Malaria poses a substantial health risk to US travelers, particularly in light of under-utilization of prophylaxis, lack of familiarity with the disease by local providers, and delays to diagnosis.
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